- Investigator
- Sandeep Grover
- Ages
- 12 Years - 50 Years
- Sexes
- Male
Clinical trials
-
A Phase 2/3, Randomized, Controlled, Masked, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Two Doses of AGTC-501, a Recombinant Adeno-associated Virus Vector Expressing RPGR (rAAV2tYF-GRK1-RPGR), Compared to an Untreated Control -
A Natural History and Outcome Measure Discovery Study of PRPF31 Mutation鈥揂ssociated Retinal Dystrophy (20226317) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening (Protocol AF) - Investigator
- Sandeep Grover
- Ages
- N/A
- Sexes
- All
-
Biobank for Potential or Known Genetic Diseases - Investigators
- Lizbeth Mellin-Sanchez, Pamela L Trapane
- Ages
- 0 Years - 100 Years
- Sexes
- All
-
Rare Disease Registry - Investigators
- Lizbeth Mellin-Sanchez, Pamela L Trapane
- Ages
- 0 Years - 100 Years
- Sexes
- All
-
A Global Prospective Observational Registry of Patients with Pompe Disease - Investigator
- Lizbeth Mellin-Sanchez
- Ages
- 0 Years - 100 Years
- Sexes
- All
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) - Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
-
Pragmatic evaluation of events and benefits of Lipid-lowering in older adults (PREVENTABLE) - Investigator
- Arshag Mooradian
- Ages
- 75 Years - 100 Years
- Sexes
- All